|
G-CSF Clinical Trials
11 actively recruiting trials across 6 locations
Also known as: Filgrastim, Granulocyte Colony Stimulating Factor, Granulocyte colony-stimulating factor, Neupogen, Granix, Zarxio, Filgrastim, filgrastim +2 more
Pipeline
Phase 1: 1Phase 2: 5Phase 3: 3Phase 1/2: 1Phase 2/3: 1
Top Sponsors
- The Affiliated People's Hospital of Ningbo University2
- University of Alabama at Birmingham1
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
- St. Jude Children's Research Hospital1
- St. Anna Kinderkrebsforschung1
Indications
- Cancer10
- Hematopoietic Stem Cell Mobilization2
- Multiple Myeloma2
- Emphysema or COPD1
- Acute T Lymphpblastic Leukemia/Lymphoma1
Other5 trials
Birmingham, Alabama1 trial
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
University of Alabama at Birmingham
Phase 1
Minneapolis, Minnesota1 trial
Auto Stem Cell Transplant for Lymphoma Patients
Masonic Cancer Center, University of Minnesota
Phase 2
New York, New York1 trial
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 2
Pittsburgh, Pennsylvania1 trial
Phase 1/2
Memphis, Tennessee1 trial
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
Phase 2
Houston, Texas1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.